Rockwell Medical (RMTI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 60%. A quarter ago, it was expected that this maker of products used in the treatment of kidney disease and anemia would post a loss of $0.08 per share when it actually produced earnings of $0.02, delivering a surprise of ...